Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model
- PMID: 18779825
- DOI: 10.1038/ijo.2008.148
Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model
Abstract
Objective: To establish that human adipocytes express functional glucose-dependent insulinotropic peptide (GIP) receptors and in particular the regulation of GIP receptor (GIPR) expression in the context of the dynamic process of adipocyte differentiation.
Design: A combination of semiquantitative real-time PCR and measurement of GIP-stimulated cAMP accumulation was used to establish the expression and functional coupling of GIPRs during in vitro differentiation of human Simpson-Golabi-Behmel syndrome (SGBS) preadipocytes.
Results: Semiquantitative real-time PCR revealed that GIPR expression was substantially increased by day 4 of differentiation, reaching a maximum around 6-8 days (approximately 200-fold increase above undifferentiated cells, n=2). We also analysed the expression of the adipocyte fatty acid binding protein (FABP4) to relate GIPR expression to a molecular differentiation marker of adipogenesis. FABP4 expression was barely detectable in undifferentiated cells. However, following exposure to adipogenic medium, FABP4 expression gradually increased, with a maximal expression level around 10 days (approximately 1,600,000-fold increase above undifferentiated cells, n=2). Thus, the increases in GIPR mRNA during adipogenesis occur earlier than FABP4, suggesting that it might represent a gene expressed early in terminal differentiation and thus plays a role in fat droplet formation. A unit of 1 microM GIP failed to raise intracellular cAMP levels above basal levels in undifferentiated cells (n=3). In stark contrast, the 9-day differentiated cells produced a robust concentration-dependent increase in cAMP accumulation following stimulation with GIP, with an EC(50) value of 2.3 nM (n=3). The maximal response represented a 9-34-fold increase in cAMP accumulation above basal levels.
Conclusions: This study demonstrates that GIPRs are expressed by human adipocytes, both GIPR mRNA and functional receptor expression being present in differentiated adipocytes but not in preadipocytes. Further investigation into the functional effects of GIP on differentiated SGBS cells could help towards understanding exactly how GIP regulates fat accumulation in human adipocytes.
Similar articles
-
Human GIP(3-30)NH2 inhibits G protein-dependent as well as G protein-independent signaling and is selective for the GIP receptor with high-affinity binding to primate but not rodent GIP receptors.Biochem Pharmacol. 2018 Apr;150:97-107. doi: 10.1016/j.bcp.2018.01.040. Epub 2018 Feb 3. Biochem Pharmacol. 2018. PMID: 29378179
-
Glucose-dependent insulinotropic peptide impairs insulin signaling via inducing adipocyte inflammation in glucose-dependent insulinotropic peptide receptor-overexpressing adipocytes.FASEB J. 2012 Jun;26(6):2383-93. doi: 10.1096/fj.11-196782. Epub 2012 Feb 24. FASEB J. 2012. PMID: 22366643
-
Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.J Clin Endocrinol Metab. 2014 May;99(5):E908-19. doi: 10.1210/jc.2013-3350. Epub 2014 Feb 10. J Clin Endocrinol Metab. 2014. PMID: 24512489
-
The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.Rev Endocr Metab Disord. 2020 Mar;21(1):165-183. doi: 10.1007/s11154-019-09536-6. Rev Endocr Metab Disord. 2020. PMID: 31933128 Review.
-
[Gastric inhibitory polypeptide (GIP) and GIP receptor (GIPR)].Nihon Rinsho. 1996 Apr;54(4):1078-82. Nihon Rinsho. 1996. PMID: 8920677 Review. Japanese.
Cited by
-
Adipocyte expression of the glucose-dependent insulinotropic polypeptide receptor involves gene regulation by PPARγ and histone acetylation.J Lipid Res. 2011 Apr;52(4):759-70. doi: 10.1194/jlr.M012203. Epub 2011 Jan 18. J Lipid Res. 2011. PMID: 21245029 Free PMC article.
-
Effect of caloric restriction with or without n-3 polyunsaturated fatty acids on insulin sensitivity in obese subjects: A randomized placebo controlled trial.BBA Clin. 2015 May 22;4:7-13. doi: 10.1016/j.bbacli.2015.05.001. eCollection 2015 Dec. BBA Clin. 2015. PMID: 26925376 Free PMC article.
-
Tirzepatide as Monotherapy Improved Markers of Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes (SURPASS-1).J Endocr Soc. 2023 Apr 22;7(5):bvad056. doi: 10.1210/jendso/bvad056. eCollection 2023 Mar 6. J Endocr Soc. 2023. PMID: 37153701 Free PMC article.
-
The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction.Diabetes Metab Syndr Obes. 2022 Apr 5;15:1023-1030. doi: 10.2147/DMSO.S351982. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 35411165 Free PMC article. Review.
-
LipiD-QuanT: a novel method to quantify lipid accumulation in live cells.J Lipid Res. 2015 Nov;56(11):2206-16. doi: 10.1194/jlr.D059758. Epub 2015 Sep 1. J Lipid Res. 2015. PMID: 26330056 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials